LEBWOHL, M.; STROBER, B.; SCHARNITZ, T.; LINABERRY, M.; HOYT, K.; BANERJEE, S.; KISA, R. M.; MARTIN, G. Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: Evaluation of Creatine Phosphokinase Elevations in the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s244, 2023. DOI: 10.25251/skin.7.supp.244. Disponível em: https://www.jofskin.org/index.php/skin/article/view/2354. Acesso em: 20 jul. 2024.